In the latest report from the Evernorth Research Institute, learn how biosimilars expand patient choice, lower specialty medication costs, and deliver meaningful savings to employers and patients.
Uncovering news and insights
We’re constantly working to unlock new ideas that can drive progress. Here you’ll find research, data analysis, and expert perspectives to help you create better outcomes for your people.
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (282)
Article
Easing the impact of GLP-1s
January 11, 2024
With GLP-1 sales forecast to exceed $100 billion, plan sponsors need the tools to control growth and expand access.
Article
Chronic conditions: The impact of delayed detection
December 19, 2023
Early detection of chronic diseases matters to the bottom line.
Article
How Accredo’s social workers, dietitians, and patient care advocates help patients thrive
December 19, 2023
Accredo specialty pharmacy employs teams of social workers, dietitians, and patient care advocates who support patients and help with a wide range of issues.
Article
Preparing the market for the evolving biosimilar landscape
December 19, 2023
With more biosimilars and the first major influx of interchangeable inflammatory biosimilars coming to market, proactive education and outreach will be crucial for successful conversions to low-cost options.
Article
Express Scripts in 2023: Supporting clients, patients, and health plans
December 19, 2023
Over the last 12 months, Express Scripts has rolled out numerous groundbreaking programs and projects. Learn about some of the most notable advancements and innovations of 2023.
Article
Improving patient outcomes: The role of population health managers
December 14, 2023
Discover how Oliver Dittus leads a team of dedicated population health managers at Evernorth, revolutionizing patient care and health care savings.
